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he transcription factor Elk-1 is a nuclear target of
mitogen-activated protein kinases and regulates
immediate early gene activation by extracellular
signals. We show that Elk-1 is also conjugated to SUMO on
either lysines 230, 249, or 254. Mutation of all three sites
is necessary to fully block SUMOylation in vitro and in
vivo. This Elk-1 mutant, Elk-1(3R), shuttles more rapidly to
nuclei of Balb/C cells fused to transfected HeLa cells.
Coexpression of SUMO-1 or -2 strongly reduces shuttling
by Elk-1 without affecting that of Elk-1(3R), indicating that
T
 
SUMOylation regulates nuclear retention of Elk-1. Accord-
ingly, overexpression of Elk-1(3R) in PC12 cells, where
cytoplasmic relocalization of Elk-1 has been linked to
differentiation, enhances neurite extension relative to Elk-1.
The effect of Elk-1, but not of the 3R mutant, was blocked
upon cotransfection with SUMO-1 or -2 and enhanced by
coexpression with mutant Ubc-9. Thus, SUMO conjugation
is a novel regulator of Elk-1 function through the control of
its nuclear-cytoplasmic shuttling.
 
Introduction
 
MAPK cascades play a central role in the cellular response to
diverse extracellular stimuli and therefore regulate numerous
processes, such as cell proliferation, fate, and differentiation.
Upon their activation, MAPKs translocate to the nucleus,
where they target transcription factors, either directly or
indirectly via the activation of other kinases, to induce the
appropriate genetic response. A primary nuclear target of
activated MAPKs is the ternary complex factor family of
ETS-domain transcription factors, namely the proteins Elk-1,
SAP-1, and NET/ERP/SAP-2/Elk-3 (Wasylyk et al., 1998).
Ternary complex factor phosphorylation drives the rapid
induction of immediate early gene transcription through a
ternary complex formed on serum response elements together
with serum response factor (SRF). This activity is mediated
by several regions of sequence and functional homology: the
NH
 
2
 
-terminal ETS DNA-binding domain, a motif that
mediates protein–protein interactions with SRF, and the
COOH-terminal transcription activation domain induced
by MAPK phosphorylation on multiple sites. Elk-1 also
contains the R motif, which represses basal transcriptional
activation, particularly in the context of fusion proteins
containing the Gal4 DNA-binding domain (Yang et al., 2002).
Recently, Yang et al. (2003) reported that this repression is
dependent on SUMOylation.
SUMO modification is an important mechanism for post-
translational regulation of protein function (Seeler and Dejean,
2003). Three SUMO isoforms exist. SUMO-1 shows 47%
homology at the protein level with SUMO-2 and -3, whereas
SUMO-2 and -3 are 95% homologous (Kim et al., 2002).
SUMOylation of target proteins is a multi-step process involv-
ing the E1-activating complex SAE1/2 and the E2-conjugating
enzyme Ubc-9 in mammalian cells (Tatham et al., 2001).
These two suffice to drive SUMO conjugation in vitro; in
vivo, this may also involve E3 factors (Seeler and Dejean,
2003). SUMO proteases have also been identified, underscor-
ing the reversible, transient nature of SUMO modification.
Many transcription regulatory proteins are SUMOylated,
which is linked to numerous nuclear processes, including
subnuclear localization, transcriptional activation or repression,
and nucleo-cytoplasmic trafficking (Seeler and Dejean, 2003).
Importantly, SUMO addition appears to occur upon nuclear
import, and mutation of the NLS in certain proteins blocks
their SUMOylation (Seeler and Dejean, 2003).
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Elk-1, like many transcriptional regulators, is localized to
the nucleus in cultured cells (Janknecht et al., 1994). This is
mediated through an NLS, present within the ETS domain,
that is independent of DNA binding (Janknecht et al.,
1994; Vanhoutte et al., 2001). In the central nervous sys-
tem, however, Elk-1 is found in both the nuclear and cyto-
plasmic compartments (Sgambato et al., 1998; Vanhoutte et
al., 2001). This redistribution is found upon NGF-driven
differentiation of PC12 cells, where neurite elongation is not
observed when Elk-1 is restricted to the nucleus (Vanhoutte
et al., 2001). Here, we report that SUMOylation of Elk-1
has an important role in its nuclear localization and thus its
ability to induce neuritogenesis in PC12 cells. All SUMO
isoforms can be conjugated to Elk-1 on any of three lysines
that lie within or near the R motif. Elk-1 mutated in all
three SUMOylation sites shuttles more rapidly than wild-
type (WT) Elk between nuclei in HeLa-Balb/C heterokary-
ons, and enhances neurite extension in PC12 cells. Shuttling
by WT Elk-1 is virtually eliminated by coexpression with
SUMO, which also blocks Elk-1–driven PC12 differentia-
tion. Thus, SUMOylation is a novel regulator of Elk-1 func-
tion that acts by controlling Elk-1 nuclear presence.
 
Results and discussion
 
Elk-1 binds to Ubc9 and can be conjugated to all three 
SUMO isoforms in vitro
 
The motif 
 
 
 
KxE, where 
 
 
 
 is an aliphatic amino acid and x is
any amino acid, is the binding site for the E2 conjugating
enzyme Ubc9 and for transfer of SUMO to the 
 
 
 
 amino
group of lysine (Rodriguez et al., 2001; Sampson et al.,
2001). Elk-1 contains three potential SUMOylation sites,
surrounding lysines 230, 249, and 254, that lie outside the
domains involved in DNA binding, interactions with SRF
and MAPKs, and transcriptional activation (Fig. 1 A). K230
and K249 lie within the R motif, which mediates repression
of basal transcriptional activity when fused to the Gal4
DNA-binding domain (Yang et al., 2002). This has recently
been linked to their SUMOylation (Yang et al., 2003). We
used several tests to evaluate SUMO conjugation to Elk-1 at
these sites in our system.
GST pull-down assays analyzed solution interactions be-
tween recombinant Elk-1 and Ubc9 (Sampson et al., 2001)
relative to PML, a known SUMO substrate, and the MAPK
p38
 
 
 
, which has no Ubc9 binding site. 
 
35
 
S-labeled Elk-1
bound to purified GST-Ubc9 but not GST alone (Fig. 1 B).
Binding to Elk-1 was more efficient than to 
 
35
 
S-PML and
was specific because 
 
35
 
S-p38
 
 
 
 did not interact with Ubc9
(Fig. 1 B). To test whether Elk is a substrate for the SUMO
pathway, 
 
35
 
S-Elk-1 was incubated in an in vitro SUMO-con-
jugation assay system containing GST-SUMO-1, recombi-
nant Ubc9, a HeLa cell fraction containing SUMO E1 activ-
ity and ATP (Rodriguez et al., 1999). A portion of 
 
35
 
S-Elk-1
 
incubated with the indicated components. The reactions were 
analyzed by SDS-PAGE as in B. Elk-1 and SUMOylated Elk-1 bands 
are indicated. The white line indicates that intervening lanes were 
spliced out. (D) Elk-1 WT and the triple mutant 3R were tested for 
conjugation to SUMO-1 (top), -2 (middle), or -3 (bottom) as in C.
Figure 1.
 
In vitro SUMOylation of Elk-1 is blocked by mutating all 
three consensus sites.
 
 (A) The major functional domains in human 
Elk-1 are indicated. Shown below is the consensus site for Ubc-9 
binding and SUMOylation 
 
 
 
KxE, where 
 
 
 
 is an aliphatic amino acid 
and K is the lysine conjugated to SUMO, as are the sequences 
surrounding the three major consensus sites in Elk-1, centered at 
lysines 230, 249, and 254. (B) 
 
35
 
S-labeled Elk-1, PML, or p38
 
 
 
 were 
incubated with GST or GST-Ubc9 bound to glutathione agarose. 
After washing, bound proteins were separated by SDS-PAGE and 
visualized by autoradiography of the dried gel. Input indicates 10% 
of the 
 
35
 
S-protein added to the incubation. White lines indicate that 
intervening lanes have been spliced out. (C) 
 
35
 
S-Elk-1, either WT or 
mutated in each consensus site (as shown below the panel) was  
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was shifted to a slower migrating species conjugated to GST-
SUMO-1 (Fig. 1 C); its appearance required the addition of
Ubc9 and GST-SUMO-1. Elk-1 could also be modified with
SUMO-2 and SUMO-3 in vitro (Fig. 1 D). To identify the
residue involved, the three candidate lysines were mutated to
arginine. No single Lys-Arg mutation blocked SUMO-1
conjugation (Fig. 1 C). Double mutation of the lysines re-
duced but did not fully block SUMOylation in vitro (not de-
picted), whereas mutation all three consensus sites eliminated
conjugation of SUMO-1, -2, and -3 (Fig. 1 D).
 
Overexpressed Elk-1 is SUMOylated on lysines 230, 
249, and 254 in cellula
 
To show that Elk-1 was modified by SUMO in cells, HeLa
cells were transfected with expression vectors for either WT
Elk or Elk3R bearing the HA epitope and one of the three
forms of SUMO with a NH
 
2
 
-terminal oligohistidine tag. To
avoid problems with SUMO peptidases, cells were lysed
with 6 M Guanidinium-HCl and the histidine-tagged pro-
teins, i.e. conjugated to SUMO, purified by metal affinity
chromatography. The purified proteins were visualized by
immunoblotting with an Elk-specific antiserum. A fraction
of overexpressed WT Elk was conjugated to (His)SUMO-1
(Fig. 2 A), which was not observed with Elk3R (Fig. 2 A).
SUMO conjugation to WT Elk, but not to Elk3R, was also
apparent upon coexpression with either (His)SUMO-2 or -3
(Fig. 2, B and C). In addition, both SUMO-2 and -3 gen-
erated a ladder of SUMOylated Elk that could reflect mod-
ification on multiple sites and/or their oligomerization
(Tatham et al., 2001). The same ladder was observed after
cotransfection of expression vectors for the single mutants
K230R, K249R, and K254R and (His)SUMO-2 (Fig. 2 D).
Nevertheless, K249 appears to be preferentially modified,
followed by K254 and finally K230, even though equivalent
levels of each mutant were expressed (Fig. 2 D). Notably,
combination of any two mutations lowered but did not
abolish SUMOylation (unpublished data). Thus, the ladder
reflects SUMO oligomerization and that any of the three
sites is a target for SUMO conjugation in transfected cells.
 
SUMO conjugation to Elk plays a role in the dynamics 
of its nuclear-cytoplasmic shuttling
 
SUMO modification correlates with nuclear localization of
certain transcriptional regulators (Seeler and Dejean, 2003),
and mutation of the NLS compromises SUMOylation of
the proteins SP100, HDAC4, Smad4, and MDM1 (Sterns-
dorf et al., 1999; Kirsh et al., 2002; Miyauchi et al., 2002;
Lin et al., 2003). To analyze intracellular localization, we
generated expression vectors for EGFP-Elk WT and 3R fu-
sion proteins. In HeLa cells, these vectors encoded proteins
of the expected molecular size recognized by an Elk-specific
antibody (not depicted). The GFP-Elk3R fusion was pre-
dominantly nuclear, like WT protein, 24 h after transfection
(Fig. 3 A). This indicates that the three K to R mutations do
not disrupt the NLS, which lies mainly in the Ets domain.
To test whether the mutant protein might show altered ki-
netics of nuclear export, we used heterokaryon analysis. HeLa
cells transfected with the WT and mutant EGFP-Elk expres-
sion vectors were fused to Balb/C mouse fibroblasts using
polyethylene glycol (Caceres et al., 1998). Nuclei of the two
cell types are easily distinguished by fluorescence (Fig. 3 B).
No EGFP signal could be detected in unfused mouse cells,
whereas EGFP staining was readily visible in both the HeLa
and mouse nuclei in the fused cells (Fig. 3 B, arrows indicate
the mouse nucleus). Analysis of EGFP staining in mouse nu-
clei at different times after the induction of cell fusion re-
vealed that EGFP-Elk3R shuttled more quickly to mouse nu-
clei (Table I). To test the effect of SUMO overexpression on
Figure 2. Conjugation of all three SUMO isoforms to Elk-1 in 
transfected cells. HeLa cells were transfected with expression vectors 
for Elk-1 WT or 3R, together with vectors for (His)SUMO-1 (A), -2 
(B), or -3 (C) as indicated below the lanes. Total proteins (Input) 
and His-tagged proteins were purified from denaturing cell lysates, 
separated on SDS-PAGE and visualized by immunoblotting for Elk-1. 
Left, Ni-NTA bound proteins; right, total protein. (D) HeLa cells 
transfected with expression vectors for (His)SUMO-2 and either WT 
Elk-1 or the mutants K230R, K249R, K254R, or 3R were analyzed as 
in A–C. 
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shuttling, we used HeLa cells that stably overexpress SUMO-1
or -2. Transfection and fusion of HeLa-SUMO-1 or -2 cells
enhanced the differential kinetics observed between WT and
mutant Elk. SUMO strongly reduced shuttling of EGFP-Elk
to the fused mouse nucleus, whereas it barely affected the
kinetics of EGFP-Elk3R transfer (Table I). Thus, Elk local-
ization to the nucleus actually reflects a balance between nu-
clear import and nuclear export. This balance is regulated by
SUMOylation because it was sensitive to coexpression with
SUMO and to mutation of the three SUMO acceptor sites in
Elk, which led to a more rapid localization of Elk3R to the
Balb/C nucleus in heterokaryons.
 
Elk3R enhances neurite outgrowth by PC12 cells 
relative to the WT protein
 
NGF treatment of PC12 cells induces their neuronal differen-
tiation, which can be easily visualized by neurite outgrowth.
Transfection of an expression vector for WT Elk leads to in-
creased PC12 differentiation (Fig. 4 A), an effect that is
linked to the relocalization of Elk to the cytoplasm (Van-
houtte et al., 2001). Therefore, Elk3R would be expected to
increase PC12 differentiation in the absence of NGF because
it shuttles more rapidly than WT Elk from the nucleus. Thus,
PC12 cells were transfected with expression vectors that en-
code HA-tagged versions of WT Elk or two mutants, Elk3R
and Elk3A. Elk3A has Ser to Ala mutations in the major
phosphorylation sites in the activation domain, which com-
promises signaling-driven reporter gene activation (Janknecht
et al., 1993). 48 h after transfection, cells were fixed and eval-
uated microscopically for neurite outgrowth and by immu-
nofluorescence for expression of GFP or HA-tagged Elk. Ex-
pression of WT Elk, Elk3A and Elk3R induced neurite
extension relative to GFP-transfected cells (Fig. 4). WT Elk
and Elk3A led to a twofold increase in the number of cells
presenting neurites relative to GFP (Fig. 4 B), suggesting that
Elk-1–driven gene expression is not important in inducing
neurite extension under basal conditions. In contrast, shut-
tling is important because differentiation was increased an-
other twofold by Elk3R (Fig. 4 B; Fig. 5, B–D). Thus, Elk ex-
pression is sufficient to increase PC12 differentiation in the
absence of NGF and Elk3R enhances this phenotype.
Importantly, SUMOylation of endogenous Elk-1 was de-
tectable in PC12 cell extracts. A band migrating at the posi-
tion expected for SUMOylated Elk-1 reacted with an Elk-1
antibody in immunoblots of denaturing lysates of PC12 cells
(Fig. 4 C). A similar band was detected using a SUMO-1 an-
tibody when Elk-1 was purified by immunoprecipitation
from nondenaturing lysates (Fig. 4 C), indicating that a pro-
portion of endogenous Elk-1 is conjugated to SUMO-1 in
PC12 cells.
 
Cotransfection of SUMO suppresses and dominant 
negative (DN) Ubc9 enhances differentiation induced 
by WT Elk
 
In light of these results, enhancing or blocking SUMOyla-
tion of WT Elk would be expected to diminish or augment
its ability to induce neurites, respectively. To test the former,
PC12 cells were cotransfected with expression vectors en-
coding either GFP-SUMO-1 or -2 and those described
above for WT and Elk3R. GFP-SUMO-1 and HA-Elk lo-
calized to the same cells, and their coexpression clearly af-
fected WT Elk-driven differentiation (Fig. 5 A), lowering
the percentage of cells with neurites to that observed with
SUMO-1 alone (Fig. 5 B). SUMO-2 showed the same re-
duction in WT Elk-driven differentiation (Fig. 5 C). In con-
Figure 3. Shuttling of EGFP-Elk-1 WT and 3R in HeLa/Balb/C 
heterokaryons. (A) HeLa cells on coverslips were transfected with 
expression vectors for EGFP-Elk-1 WT or 3R, as indicated. Cells were 
fixed 36 h later and counterstained with DAPI. (B) Heterokaryons 
between Balb/C mouse fibroblasts and HeLa cells transfected as in 
A, along with pDsRed2 to visualize the heterokaryons (not depicted). 
Cells were fixed 60 min later and counterstained with DAPI. The 
arrows indicate mouse nuclei to which EGFP-Elk-1 WT (top) and 3R 
(bottom) have shuttled.
 
Table I. 
 
Quantification of EGFP-Elk-1 WT and 3R shuttling in HeLa-Balb/C heterokaryons
 
a
 
HeLa HeLa-SUMO-1 HeLa-SUMO-2
 
Min after fusion wt 3R ratio
 
b
 
wt 3R ratio
 
b
 
wt 3R ratio
 
b
 
30 28% 48% 0.58 17% 43% 0.40 13% 37% 0.35
45 33% 56% 0.59 20% 58% 0.35 25% 58% 0.43
60 53% 70% 0.76 22% 70% 0.31 30% 77% 0.39
 
a
 
Kinetics of transfer of EGFP-Elk-1 WT and 3R to Balb/C nuclei as a function of stable overexpression of SUMO-1 or -2 in HeLa cells. The percentage of
positive Balb/C nuclei in heterokaryons relative to total number of fused cells is shown. The values are representative of at least three independent experiments.
 
b
 
wt/3R. 
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trast, SUMO-1 or -2 did not affect neurite induction by
Elk3R (Fig. 5, B and C). To test the effect of blocking
SUMOylation, we used a version of Ubc9 bearing a C35S
mutation in the catalytic site that acts as a DN inhibitor of
SUMO conjugation. Cotransfection with DN-Ubc9 in-
creased neurite induction by WT Elk to the level observed
Figure 4. Elk3R enhances PC12 differentiation relative to Elk-1 WT. 
PC12 cells were transfected with expression vectors for (HA)Elk-1 WT, 
3A or 3R, or EGFP as a control. Cells were processed 48 h later. 
(A) Elk-1 was visualized using an anti-HA antibody and F-actin with 
phalloidin-CPITC. (B) Percentage of HA-positive PC12 cells presenting 
neurites, defined by a length at least twice that of the cell body 
(Estrach et al., 2002). The numbers are representative of four exper-
iments. The error bars indicate the SEM. (C) Immunoblot detection 
of endogenous Elk-1 in native and denaturing lysates of PC12 cells 
(top), and of SUMO-1–conjugated Elk-1 in Elk-1 but not p38
MAPK 
immunoprecipitates from native lysates of PC12 cells (bottom). IgG 
denotes the signal from the antibody used for precipitation.
Figure 5. Coexpression of SUMO blocks and of DN-Ubc9 enhances 
PC12 differentiation driven by Elk-1 WT. (A) PC12 cells were 
transfected with expression vectors for pEGFP-SUMO-1 and (HA)Elk-1 
WT or 3R. Cells were processed 48 h later. Elk-1 was visualized with 
an anti-HA antibody. (B and C) PC12 cells were transfected with 
expression vectors for pEGFP (B) or pEYFP (C), (HA)Elk-1 WT or 3R, 
pEGFP-SUMO-1 (B) or -2 (C) as indicated, and processed as in A. 
Percentage of HA- and GFP-positive PC12 cells presenting neurites, 
as defined in the legend to Fig. 4 B. The numbers are representative 
of three experiments. (D) PC12 cells were transfected with expression 
vectors for HA-DN-Ubc9 and pEGFP Elk-1 WT or 3R as indicated 
and processed as described above. The numbers are representative 
of three experiments. The error bars indicate the SEM. 
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with Elk3R (Fig. 5 D), which was unaltered in the presence
of mutant Ubc9. These data show that PC12 differentiation,
a physiological indicator of Elk intracellular localization, is
strongly affected by altering the balance of SUMOylation of
Elk and thereby the dynamics of its nucleo-cytoplasmic
shuttling. This illustrates a novel functional role for Elk con-
jugation to SUMO of regulating its nuclear presence. This
would have important consequences for the other role at-
tributed to Elk SUMOylation, involving repression of Elk
basal transcriptional activation, as well as for Elk function as
a key mediator of intracellular signaling-driven transcrip-
tional activation.
 
Materials and methods
 
Reagents
 
Peroxidase-coupled secondary antibodies, glutathione agarose, protein
A-Sepharose, oligonucleotides, and phalloidin coumarin phenyl isothiocya-
nate (CPITC) were obtained from Sigma-Aldrich. All other reagents were
obtained from local suppliers.
 
Constructs and mutagenesis
 
pCDNA3-HA-Elk-1 contains the Elk-1 coding region inserted downstream
of the HA epitope in pCDNA3.1. Lysines 230, 249, and 254 were mutated
to arginine using a site-directed mutagenesis kit (Stratagene) and appropri-
ate mutant primers. Double and triple mutants were generated by subse-
quent mutagenesis. All mutations were confirmed by sequence analysis.
pGEX2T-Ubc9, pGEX2T-SUMO-1, -2, and -3, pCDNA3(His)SUMO-1, -2,
and -3, and DN-Ubc9 were a gift from R. Hay (University of St. Andrews,
St. Andrews, UK). DN-Ubc9 was subcloned in pcDNA3.1-HA. pEGFPL11-
Elk was constructed by the insertion of Elk-1 sequence into the AccI and
BamHI sites of pEGFPL11. For pEGFPL11-Elk3R, the BlpI–PflMI fragment
of pEGFPL11-Elk was replaced with that from Elk3R.
 
Cell culture, heterokaryon analysis, and immunofluorescence 
microscopy
 
HeLa and Balb/C cells were grown in DME (Invitrogen) supplemented with
10% FBS (Invitrogen) and antibiotics in 5% CO
 
2
 
 in a humidified incubator.
PC12-E2 cells were maintained in DME complemented with 5% FCS and
10% horse serum as described above. PC12-E2 cells were plated on rat tail
collagen as described previously (Estrach et al., 2002), and transfected us-
ing Lipofectamine Plus reagent (Invitrogen) according to the manufac-
turer’s instructions. HeLa cells were transfected using Fugene 6 (Roche) ac-
cording to the manufacturer’s instructions. HeLa cells stably expressing
(His)SUMO-1 and -2 were provided by R. Hay.
To study localization of EGFP-Elk WT and 3R, transfected HeLa cells
were fixed on coverslips with 3.7% formaldehyde in PBS for 10 min. After
washes in PBS, cells were then permeabilized with 0.1% Triton X-100 in
PBS, counterstained with DAPI and mounted in Mowiol. For heterokaryon
analysis (Caceres et al., 1998), 2.5 
 
 
 
 10
 
5
 
 HeLa cells were plated on cover-
slips the day before transfection. Cells were transfected with 1 
 
 
 
g EGFP-Elk
WT or 3R and 1 
 
 
 
g pDsRed2 to allow visualization of heterokaryons. 24 h
later, 10
 
6
 
 Balb/C cells were plated on the coverslips in culture medium
containing 50 
 
 
 
g/ml cycloheximide for 3 h. After a PBS wash, cells were
fused by incubation in 50% (wt/vol) polyethylene glycol. After three PBS
washes, cells were incubated for the indicated times in medium containing
100 
 
 
 
g/ml cycloheximide. Cells were processed for immunofluorescence
as described above. PC12 cells were transfected with the vectors described
in the figure legend. 48 h later cells were fixed and stained with phalloi-
din-CPITC and the anti-HA antibody as described previously (Estrach et
al., 2002).
Coverslips were examined on a DMRA fluorescence microscope (Leica)
with a Leica PL APO 40X/1.25 (PC12 cells) or 63X/1.32 (heterokaryons) oil
lens. GFP, phalloidin-CPITC, DAPI, RFP, and fluorescently tagged second-
ary antibodies were visualized using appropriate filters. Images were cap-
tured with a Photometrics CoolSnap
 
TM
 
 Fx digital camera operated via
Metamorph software, version 4.6r6 (Universal Imaging Corp.), and further
processed using Adobe Photoshop
 
®
 
 7.
 
Binding assays and in vitro SUMOylation
 
20 
 
 
 
g of GST or GST-Ubc9 were bound to 20 
 
 
 
l of glutathione agarose
beads in PBS-1 mM DTT. Non-specific binding was blocked by incubation
in 2% BSA in PBS for 1 h at 4
 
 
 
C. Elk-1 was produced using the T3-TNT
reticulocyte lysate system (Promega) and 5 
 
 
 
Ci L-[
 
35
 
S]methionine (43 TBq/
mMol, 10 
 
 
 
Ci/
 
 
 
l; Perkin-Elmer) according to the supplier’s protocol. An
aliquot of 
 
35
 
S-Elk-1 was incubated with the beads in 100 
 
 
 
l B buffer (20
mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween 20) for 30 min at RT
(Sampson et al., 2001). After three washes in B buffer, the beads were re-
suspended in SDS-PAGE sample mix, boiled, and separated by SDS-PAGE.
 
35
 
S-Elk-1 was visualized by autoradiography.
In vitro SUMOylation reactions contained 1 
 
 
 
l 
 
35
 
S-Elk-1, 2 
 
 
 
l HeLa cell
SUMO E1 activation fraction II.4 (provided by M. Rodriguez, Institut
Jaques Monod, Paris; Rodriguez et al., 1999), 10 
 
 
 
l ATP regenerating sys-
tem (50 mM Tris-HCl, pH 7.6, 5 mM MgCl
 
2
 
, 2 mM ATP, 10 mM creatine
phosphate, 3.5 U/ml creatine kinase and 0.6 U/ml inorganic pyrophos-
phatase), 10 
 
 
 
g purified GST-SUMO and 1 
 
 
 
g purified, recombinant
Ubc9. The reactions were incubated 3 h at 37
 
 
 
C, then stopped by adding
1/5 vol 10% SDS-5% 
 
 
 
-mercaptoethanol, boiled and separated by SDS-
PAGE. 
 
35
 
S-Elk-1 was visualized by autoradiography.
 
Denaturing purification and analysis of SUMO-Elk conjugates
 
HeLa cells were transfected with the appropriate Elk-1 expression vector,
along with pCDNA3(His)SUMO-1, -2, or -3. 36 h later, cells were lysed in
1 ml 6 M Guanidinium-HCl, 0.1 M NaH
 
2
 
PO
 
4
 
, 10 mM Tris-HCl, pH 8.0
(Rodriguez et al., 1999). 50 
 
 
 
l lysate was precipitated with 1 ml 5% TCA
for total protein. Lysates were incubated 3 h at RT with 75 
 
 
 
l NTA agarose
(QIAGEN) prewashed with lysis buffer. The slurry was washed with lysis
buffer; 8 M urea, 0.1 M Na
 
2
 
HPO
 
4
 
, 10 mM Tris-HCl, pH 8.0 (buffer A);
buffer A at pH 6.3; then buffer A, 6.3 containing 0.2% Triton X-100. After
denaturation, proteins were separated by SDS-PAGE, transferred to polyvi-
nylidene difluoride membranes and Elk visualized by immunoblotting as
described previously (Nissen et al., 2001).
 
SUMOylation of endogenous Elk
 
Total protein was extracted from 10
 
6
 
 PC12 cells using the denaturing
buffer above or 1% Triton lysis buffer (Nissen et al., 2001), precipitated
with 5% TCA, separated on SDS-PAGE and Elk visualized by immunoblot-
ting. For immunoprecipitation, 10
 
8
 
 PC12 cells were lysed in IP buffer (0.15 M
NaCl, 20 mM Tris-HCl, pH 7.5, 1% NP-40, 0.5% Na deoxycholate, 0.1%
SDS, 20 mM 
 
N
 
-ethyl-maleimide). After preclearing with protein A–Seph-
arose, proteins were precipitated using 40 
 
 
 
g anti-Elk (sc-355; Santa Cruz
Biotechnology, Inc.) or anti-p38 (sc-728) and protein A–Sepharose. After
three washes with IP buffer, proteins were separated on SDS-PAGE and im-
munoblotted for SUMO-1 (sc-9060).
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